Combined Exendin-4 and Rituximab Treatment Improves β-Cell Function and Delays Disease Progression in NOD Mice
The combined treatment of rituximab and exendin-4 improved insulin-related responses, helped maintain more stable blood glucose levels, improved glucose tolerance, and delayed the development of high blood sugar.